Search Results

Cost-Effectiveness of Sorafenib for Second-Line Treatment of Advanced Renal Cell Carcinoma

Authors: Hoyle, Martin; Green, Colin; Thompson-Coon, Jo; Liu, Zulian; Welch, Karen; Moxham, Tiffany; Stein, Ken

Source: Value in Health, Volume 13, Number 1, January/February 2010 , pp. 55-60(6)

Publisher: Blackwell Publishing

Platelet count less than SHARP: what does a case series reveal?

Author: Saif, M Wasif

Source: Expert Opinion on Drug Safety, Volume 9, Number 1, January 2010 , pp. 1-8(8)

Publisher: Informa Healthcare

Sorafenib as a feasible therapeutic option in haemophiliacs with hepatocellular carcinoma

Authors: LAPECORELLA, M.; NAPOLITANO, M.; TUDINI, M.; BRUERA, G.; LUCCHESI, A.; GIORDANO, A. V.; MARIANI, G.; RICEVUTO, E.

Source: Haemophilia, Volume 16, Number 1, January 2010 , pp. 185-187(3)

Publisher: Blackwell Publishing

Sorafenib: Erythema multiforme: case report

Source: Reactions, Volume 1, Number 1282, 2009-12-12 , pp. 33-34(2)

Publisher: Adis International

Sorafenib: Hyperbilirubinaemia: case report

Source: Reactions, Volume 1, Number 1279, 2009-11-21 , pp. 31-31(1)

Publisher: Adis International

Apparent Remission of a Solitary Metastatic Pulmonary Lesion in a Liver Transplant Recipient Treated with Sorafenib

Authors: Yeganeh, M.; Finn, R. S.; Saab, S.

Source: American Journal of Transplantation, Volume 9, Number 12, December 2009 , pp. 2851-2854(4)

Publisher: Blackwell Publishing

Cutaneous adverse effects related to sorafenib may be predictive of the treatment's efficacy for liver cancer

Source: Reactions, Volume 1, Number 1280, 2009-11-28 , pp. 7-7(1)

Publisher: Adis International

New Pharmacological Developments in the Treatment of Hepatocellular Cancer

Authors: Gusani, Niraj J.; Jiang, Yixing; Kimchi, Eric T.; Staveley-O'Carroll, Kevin F.; Cheng, Hua; Ajani, Jaffer A.

Source: Drugs, Volume 69, Number 18, 24 December 2009 , pp. 2533-2540(8)

Publisher: Adis International

Impact of anti-angiogenic treatments on metastatic renal cell carcinoma

Authors: Ainsworth, Nicola L; Lee, Jean SZ; Eisen, Tim

Source: Expert Review of Anticancer Therapy, Volume 9, Number 12, December 2009 , pp. 1793-1805(13)

Publisher: Expert Reviews

Update on novel agents in renal cell carcinoma

Authors: Tamaskar, Ila; Pili, Roberto

Source: Expert Review of Anticancer Therapy, Volume 9, Number 12, December 2009 , pp. 1817-1827(11)

Publisher: Expert Reviews

Sorafenib/sunitinib: Brain and mental disorders in patients with prior treatment for brain metastases: 4 case reports

Source: Reactions, Volume 1, Number 1281, 2009-12-05 , pp. 30-31(2)

Publisher: Adis International

Eruptive Keratoacanthoma-Type Squamous Cell Carcinomas in Patients Taking Sorafenib for the Treatment of Solid Tumors

Authors: SMITH, KATHLEEN J.; HALEY, HEATHER; HAMZA, SATE; SKELTON, HENRY G.

Source: Dermatologic Surgery, Volume 35, Number 11, November 2009 , pp. 1766-1770(5)

Publisher: Blackwell Publishing

Bleeding risk increased with sorafenib, sunitinib

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 4-4(1)

Publisher: Adis International

Optimizing regional infusion treatment strategies for melanoma of the extremities

Authors: Coleman, Andrew; Augustine, Christina K; Beasley, Georgia; Sanders, Gretchen; Tyler, Douglas

Source: Expert Review of Anticancer Therapy, Volume 9, Number 11, November 2009 , pp. 1599-1609(11)

Publisher: Expert Reviews

Vascular endothelial growth factor and mTOR pathways in renal cell carcinoma: differences and synergies of two targeted mechanisms

Author: Mulders, Peter

Source: BJU International, Volume 104, Number 11, December 2009 , pp. 1585-1589(5)

Publisher: Blackwell Publishing

Sorafenib + best supportive care (BSC) is more cost effective than BSC alone

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 591, 2009-11-14 , pp. 7-7(1)

Publisher: Adis International

Sorafenib: Erythema multiforme: case report

Source: Reactions, Volume 1, Number 1278, 2009-11-14 , pp. 28-28(1)

Publisher: Adis International

Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer

Authors: Merseburger, Axel S; Simon, Annika; Waalkes, Sandra; Kuczyk, Markus A

Source: Expert Review of Anticancer Therapy, Volume 9, Number 10, October 2009 , pp. 1429-1434(6)

Publisher: Expert Reviews

Sorafenib: Epithelial neoplasms and various toxicities in an elderly patient: case report

Source: Reactions, Volume 1, Number 1274, 2009-10-17 , pp. 38-38(1)

Publisher: Adis International

Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib

Authors: Lee, W.J.; Lee, J.L.; Chang, S.E.; Lee, M.W.; Kang, Y.K.; Choi, J.H.; Moon, K.C.; Koh, J.K.

Source: British Journal of Dermatology, Volume 161, Number 5, November 2009 , pp. 1045-1051(7)

Publisher: Blackwell Publishing